Skip to main content
T

TechnoPulm

TechnoPulm manufactures a handheld device that performs comprehensive pulmonary function tests, including spirometry and plethysmography, enabling diagnostics in both clinical settings and at home. This technology addresses the need for accessible and efficient respiratory disease monitoring, reducing patient exposure to hospital environments and lowering equipment costs for healthcare providers.

Ho, IsraelFounded 20161500+ followers
Updated 3 months ago

Funding

$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Pulmonologists in outpatient clinics are typically limited to spirometry for assessing lung function, which provides an incomplete picture of a patient's respiratory health. Comprehensive pulmonary function tests (PFTs), including plethysmography, lung volume measurements, diffusion capacity (DLCO), and CO₂ monitoring, are usually performed in specialized pulmonary labs, requiring patients to travel and increasing costs. This lack of readily available, comprehensive testing hinders early and accurate diagnosis and monitoring of respiratory diseases.

Solution

TechnoPulm offers the STS system, a compact, handheld device that enables comprehensive pulmonary function testing (PFT) in primary care clinics, pulmonology offices, and telemedicine settings. The STS performs cabinless plethysmography, spirometry, CO2 / fractional exhaled nitric oxide (FeNO), and diffusion testing within 30 seconds. By integrating advanced diagnostic capabilities into a portable device, the STS eliminates the need for bulky equipment and specialized labs, allowing for immediate diagnostics and monitoring. The device connects to a digital platform, supporting a respiratory telehealth solution that enables remote patient engagement and efficient clinical decision-making.

Target Audience

The primary target audience includes pulmonologists, primary care physicians, and healthcare providers in clinics, telemedicine settings, nursing homes, and rural health centers who require comprehensive and accessible pulmonary function testing.

Features

  • Handheld device for complete pulmonary function tests, including spirometry, plethysmography, CO2/FeNO, and diffusion testing
  • Rapid testing, delivering results within 30 seconds
  • Eliminates the need for specialized pulmonary labs and bulky equipment
  • Digital platform integration for telehealth and remote patient monitoring
  • Real-time insights for improved early detection and treatment initiation
  • Supports use in nursing homes, long-term care facilities, and rural healthcare settings
This profile is AI-generated and may contain inaccuracies.